Westfield Capital Management Co. LP Has $209.41 Million Holdings in Masimo Corporation $MASI

Westfield Capital Management Co. LP increased its position in Masimo Corporation (NASDAQ:MASI) by 20.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,419,250 shares of the medical equipment provider’s stock after acquiring an additional 238,047 shares during the quarter. Masimo comprises about 0.9% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 22nd biggest position. Westfield Capital Management Co. LP’s holdings in Masimo were worth $209,410,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Jupiter Asset Management Ltd. acquired a new stake in Masimo in the 3rd quarter worth $12,491,000. 4D Advisors LLC lifted its stake in shares of Masimo by 50.0% in the second quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $7,570,000 after buying an additional 15,000 shares during the period. ING Groep NV bought a new stake in shares of Masimo in the third quarter valued at about $3,069,000. Massachusetts Financial Services Co. MA grew its position in Masimo by 6.1% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,619,960 shares of the medical equipment provider’s stock worth $386,575,000 after buying an additional 149,567 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Masimo by 6.2% during the second quarter. Geode Capital Management LLC now owns 896,418 shares of the medical equipment provider’s stock valued at $150,817,000 after acquiring an additional 52,100 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Price Performance

Masimo stock opened at $175.10 on Thursday. The business’s fifty day moving average is $141.50 and its two-hundred day moving average is $143.65. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84. The firm has a market cap of $9.40 billion, a P/E ratio of -16.61, a P/E/G ratio of 1.78 and a beta of 1.26. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $194.88.

Wall Street Analysts Forecast Growth

A number of analysts have commented on MASI shares. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a research report on Tuesday, February 17th. Bank of America started coverage on Masimo in a research note on Monday, November 17th. They issued a “neutral” rating and a $162.00 target price for the company. Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. Finally, Needham & Company LLC restated a “hold” rating on shares of Masimo in a research note on Monday, December 1st. One research analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Masimo presently has a consensus rating of “Hold” and an average target price of $181.17.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.